Seasonality Snapshot

Eli Lilly (LLY)

Pharmaceuticals · US · US Healthcare & Biotech
✓ VERIFIED · 15YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
NEUTRAL SEASONALITY — August
Strongest Month
June
+4.26% avg · 81% win rate
Weakest Month
September
+0.31% avg · 53% win rate
MonthAvg ReturnWin Rate
January +2.33% 56%
February +1.82% 56%
March +1.36% 75%
April +2.48% 69%
May +3.07% 69%
June +4.26% 81%
July +0.49% 56%
August NOW +3.27% 50%
September +0.31% 53%
October +0.85% 60%
November +4.06% 80%
December +3.75% 60%
These figures are computed from 15 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Eli Lilly seasonality — common questions

What is Eli Lilly's best month historically?
Historically, June has been Eli Lilly's strongest month, averaging +4.26% with a 81% win rate over 15 years of data. September has been the weakest at +0.31%.
Is Eli Lilly seasonal?
Eli Lilly shows a measurable seasonal pattern: its best and worst months differ by 3.95 percentage points on average. These figures come from 15 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Eli Lilly historically perform in August?
Eli Lilly is currently in August, which has historically averaged +3.27% with a 50% win rate. That is a historically neutral window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.